Clinical trial
Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
NCT00051324 · Jordan Schultz, Other · Active, not recruiting
Key facts
| NCT number | NCT00051324 |
|---|---|
| Title | Neurobiological Predictors of Huntington's Disease (PREDICT-HD) |
| Official title | Neurobiological Predictors of Huntington's Disease Trial |
| Acronym | PREDICT-HD |
| Lead sponsor | Jordan Schultz, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Huntington Disease |
| Enrollment | 1,700 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 30, 2025 |
| Completion | Jun 30, 2025 |
| First posted | Jan 9, 2003 |
| Last update posted | Jan 14, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: